for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Grocery Outlet Holding Corp

GO.OQ

Latest Trade

33.05USD

Change

0.15(+0.46%)

Volume

246,057

Today's Range

32.41

 - 

33.14

52 Week Range

32.23

 - 

48.86

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
32.90
Open
32.72
Volume
246,057
3M AVG Volume
19.61
Today's High
33.14
Today's Low
32.41
52 Week High
48.86
52 Week Low
32.23
Shares Out (MIL)
95.71
Market Cap (MIL)
3,148.78
Forward P/E
33.79
Dividend (Yield %)
--

Next Event

Q2 2021 Grocery Outlet Holding Corp Earnings Release

Latest Developments

More

Grocery Outlet Holding Corp Announces First Quarter Fiscal 2021 Financial Results

Grocery Outlet Holding Corp Posts Q4 EPS Of $0.24

Grocery Outlet Holding Reports Q3 EPS Of $0.41

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Grocery Outlet Holding Corp

Grocery Outlet Holding Corp. is a supermarket company that owns and operates retail stores. The Company’s stores offer a fun, treasure hunt shopping experience. The Company offers a discount, overstocked and closeout products from name brand and private label suppliers. The Company offers products at prices generally 40% to 70% below those of conventional retailers. The Company has stores in California, Oregon, Washington, Idaho, Nevada and Pennsylvania.

Industry

Retail (Grocery)

Contact Info

5650 Hollis St

EMERYVILLE, CA

94608-2597

United States

+1.510.8451999

https://groceryoutlet.com/

Executive Leadership

Erik D. Ragatz

Independent Chairman of the Board

Robert Joseph Sheedy

President

Eric J. Lindberg

Chief Executive Officer, Director

S. MacGregor Read

Non-Executive Vice Chairman of the Board

Charles C. Bracher

Chief Financial Officer, Executive Vice President

Key Stats

2.60 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

2.6K

2020

3.1K

2021(E)

3.2K
EPS (USD)

2019

0.790

2020

1.140

2021(E)

0.967
Price To Earnings (TTM)
28.90
Price To Sales (TTM)
1.01
Price To Book (MRQ)
3.31
Price To Cash Flow (TTM)
18.14
Total Debt To Equity (MRQ)
47.44
LT Debt To Equity (MRQ)
47.44
Return on Investment (TTM)
5.10
Return on Equity (TTM)
4.69

Latest News

Latest News

BRIEF-Third Point Dissolves Share Stake In Fox Corp, Campbell Soup

* THIRD POINT LLC DISSOLVES SHARE STAKE IN FOX CORP - SEC FILING

U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power, on Tuesday. HIGHLIGHTS * Digital Realty Trust Inc : Citigroup cuts to neutral from buy * Pilgrims...

U.S. RESEARCH ROUNDUP- American Tower, Ferrari, Walt Disney

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including American Tower, Ferrari and Walt Disney, on Tuesday. HIGHLIGHTS * American Tower Corp : Credit Suisse initiates with outperform rating * CNX Resources Corp...

BRIEF-Grocery Outlet Holding Says Amends S-1 Registration Statement To Raise Size Of Common Stock Offering To 12.5 Mln Shares From 10 Mln Shares

* GROCERY OUTLET HOLDING SAYS AMENDS S-1 REGISTRATION STATEMENT TO RAISE SIZE OF COMMON STOCK OFFERING TO 12.5 MILLION SHARES FROM 10 MILLION SHARES - SEC FILING

BRIEF-Third Point Dissolves In Microsoft, Paypal and Godaddy

* THIRD POINT LLC DISSOLVES SHARE STAKE IN MICROSOFT CORP - SEC FILING

IFR US ECM Weekly Wrap-up

WEEKLY TOTAL $4.47bn – IPO $1.83bn – ABB/BLOCK $522m – FOLLOW-ON $1.77bn – CB $350m Monday

IFR US ECM Calendar

Alector (US, biotech) – $208.9m FO. 8.35m shares (100% prim) at $25.00 versus $25.94 last sale and $25.34 at launch. MS, GS, BOFA, COWN. Upsized from 5.1m on 1/29 to 7.0m shares.

IFR US ECM Calendar

Black Diamond Therapeutics (US, biotech) - $201.2m IPO. 10.59m shares (100% prim) at $19.00 versus $16-$18 marketing. JPM, JEFF, COWN. Upsized from 8.9m shares.

UPDATE 1-IFR US ECM Calendar

BioHaven Pharmaceutical (US, biotech) – $250m ABB. 4.83m shares (100% prim) at $51.75 versus $51.75-$53.00 marketing range and $56.44 last sale. GS.

CORRECTED-IFR US ECM Calendar

BioHaven Pharmaceutical (US, biotech) – $250m ABB. 4.83m shares (100% prim) at $51.75 versus $51.75-$53.00 marketing range and $56.44 last sale. GS.

IFR US ECM Calendar

Denali Therapeutics (US, biotech) – $180m FO. 7.83m shares (100% prim) at $23.00 versus $24.84 last sale and $27.98 at launch. GS, JPM, JEFF. Upsized from $150m at launch.

IFR US ECM Calendar

Concert Pharmaceuticals (US, biotech) – $65m ABB. 6.55m shares (100% prim) at $9.92 versus $9.92 last sale. JEFF. Upsized from $50m. Offering includes 1.8m of pre-funded warrants.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up